IP Library › Assignment 036796/0562
Patent Assignment
Reel/Frame 036796/0562

Grant of Security Interest in United States Patents

Recorded: 2015-10-06 Pages: 31
Assignor
NEKTAR THERAPEUTICS
Executed: 2015-10-05
Assignee
TC LENDING, LLC, AS COLLATERAL AGENT
301 COMMERCE STREET, SUITE 3300, FORT WORTH, TEXAS, 76102
Covered Properties (370)
Acid Salt Forms of Polymer-Drug Conjugates and Alkoxylation Methods
Patent: 9,320,808 →
Application: 14/284,067 →
Publication: US US20150105519A1
Salt Form of a Multi-Arm Polymer-Drug Conjugate
Patent: 9,226,969 →
Application: 13/510,587 →
Publication: US US20130231359A1
Aerosolization Device
Patent: 8,555,874 →
Application: 12/936,373 →
Publication: US US20110108025A1
Aerosolization Device
Patent: 9,144,650 →
Application: 14/040,277 →
Publication: US US20140020680A1
Aerosolization Device
Patent: 9,242,054 →
Application: 14/832,344 →
Publication: US US20150359980A1
Oligomer-Beta Blocker Conjugates
Patent: 9,782,488 →
Application: 12/530,412 →
Publication: US US20100227865A1
Multi-Arm Polymer Prodrugs
Patent: 7,744,861 →
Application: 10/943,799 →
Publication: US US20050112088A1
Multi-Arm Polymer Prodrugs
Patent: 8,394,365 →
Application: 11/948,767 →
Publication: US US20090074704A1
Multi-Arm Polymer Prodrugs
Patent: 8,263,062 →
Application: 12/709,800 →
Publication: US US20100152414A1
Multi-Arm Polymer Prodrugs
Patent: 8,318,145 →
Application: 12/728,072 →
Publication: US US20100190933A1
Multi-Arm Polymer Prodrugs
Patent: 8,771,662 →
Application: 13/765,433 →
Publication: US US20130158062A1
Multi-Arm Polymer Prodrugs
Patent: 9,333,200 →
Application: 14/323,993 →
Publication: US US20140323514A1
Branched Polymers and Their Conjugates
Patent: 7,026,440 →
Application: 10/290,082 →
Publication: US US20030143596A1
Branched Polymers and Their Conjugates
Patent: 7,872,072 →
Application: 11/336,695 →
Publication: US US20060178475A1
Branched Polymers
Patent: 8,273,833 →
Application: 12/963,170 →
Publication: US US20110077362A1
Branched Polymers
Patent: 8,440,816 →
Application: 13/593,861 →
Publication: US US20120322134A1
Branched Polymers
Patent: 8,809,453 →
Application: 13/865,912 →
Publication: US US20130295639A1
Branched Polymers
Patent: 9,187,569 →
Application: 14/334,223 →
Publication: US US20140329994A1
Compositions and Methods for Achieving Sustained Therapeutic Drug Concentrations in a Subject
Patent: 8,906,353 →
Application: 13/120,551 →
Publication: US US20110269789A1
Methods for Treating Humans Having Brain Cancer
Patent: 9,801,873 →
Application: 14/555,440 →
Publication: US US20150087668A1
Compositions comprising two different populations of polymer-active agent conjugates
Patent: 9,539,337 →
Application: 11/009,304 →
Publication: US US20050186174A1
Conjugates Having a Degradable Linkage and Polymeric Reagents Useful in Preparing Such Conjugates
Patent: 8,252,275 →
Application: 11/454,971 →
Publication: US US20060293499A1
Pharmaceutical Compositions and Methods for Delivering Such Compositions
Patent: 8,435,505 →
Application: 13/525,068 →
Publication: US US20120258912A1
Methods for Preparing Conjugates
Patent: 8,703,115 →
Application: 13/788,179 →
Publication: US US20130184443A1
Methods for Preparing Polymeric Reagents
Patent: 8,911,718 →
Application: 14/109,302 →
Publication: US US20140107349A1
Methods for Preparing Polymeric Reagents
Patent: 9,090,740 →
Application: 14/570,705 →
Publication: US US20150141665A1
Methods for Preparing Polymeric Reagents
Patent: 9,381,254 →
Application: 14/807,244 →
Publication: US US20160022830A1
Conjugates having a releasable linkage
Application: 61/137,873 →
Conjugates Having a Releasable Linkage
Patent: 8,575,102 →
Application: 13/057,042 →
Publication: US US20110190209A1
Conjugates of a Cholinesterase Moiety and a Polymer
Application: 12/991,402 →
Publication: US US20110135623A1
Conjugates of a Gm-Csf Moiety and a Polymer
Application: 13/782,842 →
Publication: US US20140044672A1
Conjugates of a lysosomal enzyme moiety and a water soluble polymer
Application: 61/205,059 →
Conjugates of a Lysosomal Enzyme Moiety and a Water Soluble Polymer
Application: 13/142,813 →
Publication: US US20110318322A1
Conjugates of an Il-2 Moiety and a Polymer
Application: 61/413,236 →
Conjugates of an IL-2 Moiety and a Polymer
Patent: 9,861,705 →
Application: 13/884,901 →
Publication: US US20140328791A1
Conjugates of an Anti-Tnf-Alpha Antibody
Patent: 9,101,670 →
Application: 12/296,268 →
Publication: US US20100021481A1
Conjugates of an Anti-Tnf-Alpha Antibody
Patent: 9,636,412 →
Application: 14/819,212 →
Publication: US US20160030587A1
Conjugates of an Epo Moiety and a Polymer
Patent: 7,714,114 →
Application: 11/357,936 →
Publication: US US20060182711A1
Polymer Conjugates of Glp-1
Patent: 8,293,869 →
Application: 12/086,687 →
Publication: US US20100210505A1
Polymer Conjugates of Glp-1
Patent: 8,580,919 →
Application: 13/617,756 →
Publication: US US20130096258A1
Conjugates of Small-Interfering Nucleic Acids
Patent: 9,433,684 →
Application: 12/737,833 →
Publication: US US20120100096A1
Complexes of Small-Interfering Nucleic Acids
Patent: 9,089,610 →
Application: 13/059,624 →
Publication: US US20110213013A1
Crystalline Naloxol-Peg Conjugate
Patent: 9,012,469 →
Application: 13/823,953 →
Publication: US US20150038524A1
Crystalline Naloxol-Peg Conjugate
Patent: 9,149,539 →
Application: 14/645,347 →
Publication: US US20150283257A1
Cyanovirin Variant-Polymer Conjugates
Patent: 7,267,941 →
Application: 10/742,465 →
Publication: US US20040258706A1
Cyanovirin Variant-Polymer Conjugates
Patent: 7,547,509 →
Application: 11/832,925 →
Publication: US US20080015151A1
Compositions, Dosage Forms, and Co-Administration of an Opioid Agonist Compound and a Non-Steroidal Anti-Inflammatory Drug
Patent: 9,457,024 →
Application: 14/356,486 →
Publication: US US20140336214A1
Factor Ix Moiety-Polymer Conjugates Having a Releasable Linkage
Patent: 8,507,653 →
Application: 12/006,073 →
Publication: US US20080188414A1
Heterobifunctional Poly(Ethylene Glycol) Derivatives and Methods for Their Preparation
Patent: 6,448,369 →
Application: 09/186,759 →
Heterobifunctional Poly(Ethylene Glycol) Derivatives and Methods for Their Preparation
Patent: 6,864,327 →
Application: 10/071,469 →
Publication: US US20020072573A1
Heterobifunctional Poly (Ethylene Glycol) Derivatives and Methods for Their Preparation
Patent: 7,642,323 →
Application: 11/016,383 →
Publication: US US20050176896A1
Heterobifunctional Poly(Ethylene Glycol) Derivatives and Methods for Their Preparation
Patent: 8,940,801 →
Application: 12/620,011 →
Publication: US US20100063328A1
Heterobifunctional Poly(Ethylene Glycol) Derivatives and Methods for Their Preparation
Application: 14/581,263 →
Publication: US US20150107489A1
Hydrogels Derived from Chitosan and Poly(Ethylene Glycol) or Related Polymers
Patent: 6,602,952 →
Application: 09/590,622 →
Hydrolytically Degradable Alkylene Oxide Based Polymers
Patent: 9,040,060 →
Application: 13/108,616 →
Publication: US US20110217343A1
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
Patent: 6,413,507 →
Application: 09/469,418 →
Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)
Patent: 6,514,491 →
Application: 09/842,977 →
Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)
Patent: 6,461,602 →
Application: 09/842,976 →
Publication: US US20010027212A1
Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)
Patent: 6,541,015 →
Application: 09/842,514 →
Publication: US US20010046481A1
Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)
Patent: 6,899,867 →
Application: 10/361,451 →
Publication: US US20040013637A1
Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)
Patent: 7,060,259 →
Application: 11/033,547 →
Publication: US US20050147583A1
Hydrolytically Degradable Carbamate Derivatives of Poly (Ethylene Glycol)
Patent: 7,608,253 →
Application: 11/414,456 →
Publication: US US20060193823A1
Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)
Patent: 7,988,956 →
Application: 12/559,320 →
Publication: US US20100105946A1
Hydrolytically Degradable Polymers and Hydrogels Made Therefrom
Patent: 6,348,558 →
Application: 09/459,312 →
Hydrolytically Degradable Polymers and Hydrogels Made Therefrom
Patent: 7,074,878 →
Application: 10/412,642 →
Hydrolytically Degradable Polymers and Hydrogels Made Therefrom
Patent: 7,259,224 →
Application: 11/377,973 →
Publication: US US20060160983A1
Hydrolytically Degradable Polymers and Hydrogels Made Therefrom
Patent: 7,608,678 →
Application: 11/890,162 →
Publication: US US20070276116A1
Hydrolytically Degradable Polymers and Hydrogels Made Therefrom
Patent: 7,772,357 →
Application: 12/559,162 →
Publication: US US20100004392A1
Hydrolytically Degradable Polymers and Hydrogels Made Therefrom
Patent: 7,910,685 →
Application: 12/826,664 →
Publication: US US20100267895A1
Hydrolytically Degradable Polymers and Hydrogels Made Therefrom
Patent: 8,119,756 →
Application: 13/027,218 →
Publication: US US20110135592A1
Hydrolytically Degradable Polymers and Hydrogels Made Therefrom
Patent: 8,283,434 →
Application: 13/344,434 →
Publication: US US20120108785A1
Hydrolytically Stable Maleimide-Terminated Polymers
Patent: 7,432,330 →
Application: 10/751,274 →
Publication: US US20040204548A1
Hydrolytically Stable Maleimide-Terminated Polymers
Patent: 7,432,331 →
Application: 11/091,024 →
Publication: US US20060009590A1
Hydrolytically Stable Maleimide-Terminated Polymers
Patent: 8,106,131 →
Application: 12/229,650 →
Publication: US US20090012241A1
Hydrolytically Stable Maleimide-Terminated Polymers
Patent: 8,227,555 →
Application: 13/336,886 →
Publication: US US20120123065A1
Hydrolytically Stable Maleimide-Terminated Polymers
Patent: 8,835,556 →
Application: 13/474,548 →
Publication: US US20120226022A1
Hydroxyapatite-Targeting Multiarm Polymers and Conjugates Made Therefrom
Patent: 8,440,787 →
Application: 12/738,980 →
Publication: US US20100286355A1
Hydroxyapatite-Targeting Multiarm Polymers and Conjugates Made Therefrom
Patent: 8,815,227 →
Application: 13/865,021 →
Publication: US US20130331549A1
Hydroxyapatite-Targeting Multiarm Polymers and Conjugates Made Therefrom
Patent: 9,173,947 →
Application: 14/335,719 →
Publication: US US20140329990A1
Hydroxyapatite-Targeting Poly (Ethylene Glycol) and Related Polymers
Patent: 6,436,386 →
Application: 09/712,536 →
Hydroxypatite-Targeting Poly(Ethylene Glycol) and Related Polymers
Patent: 7,829,074 →
Application: 10/398,845 →
Publication: US US20040023852A1
Hydroxyapatite-Targeting Poly(Ethylene Glycol) and Related Polymers
Patent: 8,372,422 →
Application: 12/899,521 →
Publication: US US20110020422A1
Hydroxyapatite-Targeting Poly(Ethylene Glycol) and Related Polymers
Patent: 8,784,849 →
Application: 13/764,399 →
Publication: US US20130149355A1
Maleamic Acid Polymer Derivatives and Their Bioconjugates
Patent: 7,329,721 →
Application: 10/750,996 →
Publication: US US20040167287A1
Maleamic Acid Polymer Derivatives and Their Bioconjugates
Patent: 7,659,361 →
Application: 11/904,990 →
Publication: US US20080146771A1
Maleamic Acid Polymer Derivatives and Their Bioconjugates
Patent: 7,994,272 →
Application: 12/642,413 →
Publication: US US20100113329A1
Maleamic Acid Polymer Derivatives and Their Bioconjugates
Patent: 8,304,511 →
Application: 13/172,043 →
Publication: US US20110262379A1
Methods and Apparatus for Particle Formation
Patent: 6,576,262 →
Application: 09/700,441 →
Method and Apparatus for the Formation of Particles
Patent: 6,063,138 →
Application: 08/765,540 →
Method and Apparatus for the Formation of Particles
Patent: 6,440,337 →
Application: 09/380,025 →
Method for Preparing Branched Functionalized Polymers Using Branched Polyol Cores
Patent: 8,568,705 →
Application: 11/458,269 →
Publication: US US20070031371A1
Method for Preparing Branched Functionalized Polymers Using Branched Polyol Cores
Patent: 8,901,246 →
Application: 14/051,246 →
Publication: US US20140039205A1
Method for preparing functionalized polymers from polymer alcohols
Patent: 8,604,159 →
Application: 10/897,386 →
Publication: US US20050054816A1
Maleimidyl Polymer Derivatives
Application: 14/074,421 →
Publication: US US20140073802A1
Method for Preparing Polymer Maleimides
Patent: 7,872,082 →
Application: 11/490,268 →
Publication: US US20070049688A1
Method for Preparing Conjugates Using Polymer Maleimides
Patent: 8,058,385 →
Application: 12/940,009 →
Publication: US US20110046315A1
Method for Preparing Polymer Maleimides
Patent: 8,227,558 →
Application: 13/252,761 →
Publication: US US20120022220A1
Compositions Comprising Conjugates and Maleamic Acid-Terminated, Water-Soluble Polymers
Application: 13/529,224 →
Publication: US US20120271000A1
Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
Patent: 6,376,604 →
Application: 09/740,556 →
Publication: US US20010056171A1
Method for the Preparation of 1-Benzotriazolyl Carbonate Esters of Poly(Ethylene Glycol)
Patent: 6,710,125 →
Application: 10/068,371 →
Publication: US US20020086939A1
Method for the Preparation of 1-Benzotriazolyl Carbonate Esters of Poly(Ethylene Glycol)
Patent: 6,624,246 →
Application: 10/068,349 →
Publication: US US20020099133A1
Method for the Preparation of 1-Benzotriazolyl Carbonate Esters of Poly (Ethylene Glycol)
Patent: 7,101,932 →
Application: 10/727,337 →
Publication: US US20040157991A1
Method for the Preparation of 1-Benzotriazolyl Carbonate Esters of Poly(Ethylene Glycol)
Patent: 7,378,469 →
Application: 11/492,133 →
Publication: US US20060264578A1
Method for the Preparation of 1-Benzotriazolyl Carbonate Esters of Poly (Ethylene Glycol)
Patent: 7,544,738 →
Application: 12/150,136 →
Publication: US US20080227872A1
Method for the Preparation of 1-Benzotriazolyl Carbonate Esters of Poly(Ethylene Glycol)
Patent: 7,723,432 →
Application: 12/433,874 →
Publication: US US20090215910A1
Method Involving 1-Benzotriazolyl Carbonate Esters of Polymers
Patent: 7,977,427 →
Application: 12/756,905 →
Publication: US US20100197806A1
Method Involving 1-Benzotriazolyl Carbonate Esters of Polymers
Patent: 8,299,173 →
Application: 13/154,917 →
Publication: US US20110237746A1
Method Involving 1-Benzotriazolyl Carbonate Esters of Poly(ethylene glycol)
Patent: 8,563,651 →
Application: 13/664,021 →
Publication: US US20130053514A1
Method Involving 1-Benzotriazolyl Carbonate Esters of Poly(ethylene glycol)
Patent: 8,816,002 →
Application: 14/059,020 →
Publication: US US20140051845A1
Method Involving 1-Benzotriazolyl Carbonate Esters of Poly(Ethylene Glycol)
Patent: 9,346,917 →
Application: 14/467,634 →
Publication: US US20150191568A1
Method of Preparing Carboxylic Acid Functionalized Polymers
Patent: 8,067,505 →
Application: 13/023,960 →
Publication: US US20110130539A1
Method of Preparing Carboxylic Acid Functionalized Polymers
Application: 13/922,020 →
Publication: US US20130281634A1
Method of Preparing Maleimide Functionalized Polymers
Patent: 7,790,835 →
Application: 11/004,631 →
Publication: US US20050176922A1
Intermediates Useful in the Preparation of Maleimide Functionalized Polymers
Patent: 8,039,579 →
Application: 12/822,148 →
Publication: US US20100261841A1
Intermediates Useful in the Preparation of Maleimide Functionalized Polymers
Patent: 8,258,324 →
Application: 13/233,717 →
Publication: US US20120004422A1
Intermediates Useful in the Preparation of Maleimide Functionalized Polymers
Patent: 8,653,286 →
Application: 13/568,518 →
Publication: US US20120302761A1
Intermediates Useful in the Preparation of Maleimide Functionalized Polymers
Patent: 8,895,759 →
Application: 14/153,783 →
Publication: US US20140128619A1
Method of Preparing Propionic Acid-Terminated Polymers
Patent: 7,608,663 →
Application: 11/040,142 →
Publication: US US20050171291A1
Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents
Patent: 7,767,784 →
Application: 11/497,463 →
Publication: US US20080064851A1
Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents
Patent: 8,193,306 →
Application: 12/820,124 →
Publication: US US20100256310A1
Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents
Patent: 8,461,295 →
Application: 13/463,686 →
Publication: US US20120214952A1
Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents
Patent: 8,809,489 →
Application: 13/894,707 →
Publication: US US20130253203A1
Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents
Patent: 9,334,364 →
Application: 14/329,612 →
Publication: US US20140323742A1
Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof
Patent: 7,312,301 →
Application: 10/751,010 →
Publication: US US20050143484A1
Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof
Patent: 7,598,338 →
Application: 11/904,985 →
Publication: US US20080033105A1
Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof
Patent: 8,097,695 →
Application: 12/547,369 →
Publication: US US20100004424A1
Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof
Patent: 8,247,598 →
Application: 13/325,936 →
Publication: US US20120088927A1
Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof
Patent: 8,450,390 →
Application: 13/554,292 →
Publication: US US20120289609A1
Method for Preparing Water-Soluble Polymer Derivatives Bearing a Terminal Carboxylic Acid
Patent: 7,569,214 →
Application: 10/659,735 →
Publication: US US20050036978A1
Method for Preparing Water-Soluble Polymer Derivatives Bearing a Terminal Carboxylic Acid
Patent: 8,182,801 →
Application: 12/496,294 →
Publication: US US20090264600A1
Method for Preparing Water-Soluble Polymer Derivatives Bearing a Terminal Carboxylic Acid
Patent: 8,435,504 →
Application: 13/453,769 →
Publication: US US20120209027A1
Method for Preparing Water-Soluble Polymer Derivatives Bearing an N-Succinimidyl Ester
Patent: 8,784,791 →
Application: 13/856,704 →
Publication: US US20130231490A1
Orthoester Compound
Patent: 9,045,494 →
Application: 14/303,285 →
Publication: US US20140296541A1
Methods of Treating CYP2D6 Alternative Metabolizers
Application: 12/993,807 →
Publication: US US20110160186A1
Monoconjugated Chitosans as Delivery Agents for Small Interfering Nucleic Acids
Patent: 8,916,693 →
Application: 13/496,170 →
Publication: US US20120238735A1
Multi-Arm Block Copolymers as Drug Delivery Vehicles
Patent: 6,730,334 →
Application: 10/054,662 →
Publication: US US20020156047A1
Multi-Arm Block Copolymers as Drug Delivery Vehicles
Patent: 6,838,528 →
Application: 10/795,913 →
Publication: US US20040170595A1
Multi-Arm Block Copolymers as Drug Delivery Vehicles
Patent: 7,265,186 →
Application: 10/984,679 →
Publication: US US20050147681A1
Multi-Arm Block Copolymers as Drug Delivery Vehicles
Patent: 7,589,157 →
Application: 11/894,445 →
Publication: US US20080234430A1
Multi-Arm Block Copolymers as Drug Delivery Vehicles
Patent: 8,071,692 →
Application: 12/538,013 →
Publication: US US20090299050A1
Multi-Arm Block Copolymers as Drug Delivery Vehicles
Patent: 8,338,545 →
Application: 13/287,852 →
Publication: US US20120046422A1
Multi-Arm Block Copolymers as Drug Delivery Vehicles
Patent: 8,586,681 →
Application: 13/680,953 →
Publication: US US20130144014A1
Multi-Arm Polypeptide-Poly (Ethylene Glycol) Block Copolymers as Drug Delivery Vehicles
Patent: 7,316,811 →
Application: 10/746,567 →
Publication: US US20040161403A1
Multi-Arm Polypeptide-Poly(Ethylene Glycol) Block Copolymers as Drug Delivery Vehicles
Patent: 7,976,834 →
Application: 11/985,443 →
Publication: US US20080069902A1
Multi-Arm Polypeptide-Poly(Ethylene Glycol) Block Copolymers as Drug Delivery Vehicles
Patent: 8,323,632 →
Application: 13/152,144 →
Publication: US US20110237747A1
Method for Preparing a Polymer Conjugate
Patent: 8,354,549 →
Application: 12/515,736 →
Publication: US US20100010194A1
Method for Preparing a Polymer Conjugate
Patent: 8,541,608 →
Application: 13/680,764 →
Publication: US US20130079533A1
Method for Preparing a Polymer Conjugate
Patent: 8,937,180 →
Application: 14/021,399 →
Publication: US US20140005419A1
Multi-Arm Polymeric Alkanoate Conjugates
Patent: 8,637,466 →
Application: 13/058,320 →
Publication: US US20110200550A1
Multi-Arm Polymeric Alkanoate Conjugates
Patent: 8,962,566 →
Application: 14/137,090 →
Publication: US US20140113961A1
Multi-Arm Polymeric Alkanoate Conjugates
Patent: 9,220,790 →
Application: 14/591,601 →
Publication: US US20150133534A1
Multi-Arm Polymeric Prodrug Conjugates of Cabazitaxel-Based Compounds
Application: 13/995,902 →
Publication: US US20130345298A1
Multi-Arm Polymeric Prodrug Conjugates of Pemetrexed-Based Compounds
Application: 13/995,415 →
Publication: US US20130338175A1
Multi-Arm Polymeric Prodrug Conjugates of Taxane-Based Compounds
Application: 13/995,287 →
Publication: US US20130331443A1
Multiarmed, Monofunctional, Polymer for Coupling to Proteins and Surfaces
Patent: 5,932,462 →
Application: 08/443,383 →
Negatively Biased Sealed Nebulizers Systems and Methods
Patent: 9,084,862 →
Application: 13/384,575 →
Publication: US US20120118284A1
Negatively Biased Sealed Nebulizer Systems and Methods
Patent: 9,682,201 →
Application: 14/742,464 →
Publication: US US20150283336A1
N-Maleimidyl Polymer Derivatives
Patent: 6,602,498 →
Application: 09/790,250 →
Publication: US US20010044526A1
N-Maleimidyl Polymer Derivatives
Patent: 6,911,197 →
Application: 10/408,834 →
Publication: US US20040109841A1
N-maleimidyl polymer derivatives
Patent: 8,454,946 →
Application: 11/134,076 →
Publication: US US20060013797A1
N-Maleimidyl Polymer Derivatives
Patent: 8,765,111 →
Application: 13/890,799 →
Publication: US US20130253207A1
N-Maleimidyl Polymer Derivatives
Patent: 8,992,902 →
Application: 14/283,788 →
Publication: US US20140256957A1
N-Maleimidyl Polymer Derivatives
Patent: 9,169,350 →
Application: 14/627,917 →
Publication: US US20150166725A1
Non-Ring Hydroxy Substituted Taxanes and Methods for Synthesizing the Same
Patent: 9,199,954 →
Application: 13/995,445 →
Publication: US US20140024845A1
N-Optionally Substituted Aryl-2-Oligomer-3-Alkoxypropionamides
Patent: 9,226,971 →
Application: 13/879,603 →
Publication: US US20140296334A1
Novel Reagents
Patent: 9,095,620 →
Application: 12/921,778 →
Publication: US US20110071093A1
Oligomer Conjugates of Heteropentacyclic Nucleosides
Patent: 8,466,276 →
Application: 12/918,780 →
Publication: US US20110039797A1
Oligomer Conjugates of Heteropentacyclic Nucleosides
Patent: 8,778,898 →
Application: 13/897,116 →
Publication: US US20130261072A1
Oligomer Conjugates of Heteropentacyclic Nucleosides
Patent: 9,149,538 →
Application: 14/298,580 →
Publication: US US20140288295A1
Hydroxylated Tricyclic Compounds
Patent: 9,090,535 →
Application: 13/992,587 →
Publication: US US20130317114A1
Oligomer Conjugates of Lidocaine and Its Derivatives
Application: 12/682,778 →
Publication: US US20100303753A1
Oligomer-Amino Acid Conjugates
Patent: 9,192,681 →
Application: 13/203,066 →
Publication: US US20120053237A1
Oligomer-Anticholinergic Agent Conjugates
Patent: 8,389,759 →
Application: 12/530,424 →
Publication: US US20100168232A1
Oligomer-Anticholinergic Agent Conjugates
Patent: 9,126,926 →
Application: 13/757,219 →
Publication: US US20130150441A1
Oligomer-Antihistamine Conjugates
Application: 14/640,982 →
Publication: US US20150174264A1
Oligomer-Aryloxy-Substituted Propanamine Conjugates
Patent: 9,233,165 →
Application: 12/936,894 →
Publication: US US20110071207A1
Oligomer-Bis-Chromonyl Compound Conjugates
Patent: 9,095,621 →
Application: 12/989,074 →
Publication: US US20110112183A1
Oligomer-Bis-Chromonyl Compound Conjugates
Patent: 9,233,169 →
Application: 14/627,370 →
Publication: US US20150157734A1
Oligomer-Calcimimetic Conjugates and Related Compounds
Patent: 8,722,732 →
Application: 13/433,100 →
Publication: US US20120238621A1
Oligomer-Calcimimetic Conjugates and Related Compunds
Patent: 9,421,275 →
Application: 14/223,572 →
Publication: US US20140323565A1
Oligomer-Calcium Channel Blocker Conjugates
Patent: 8,748,648 →
Application: 12/674,139 →
Publication: US US20110098273A1
Oligomer-Calcium Channel Blocker Conjugates
Patent: 9,132,200 →
Application: 14/266,317 →
Publication: US US20140323529A1
Oligomer-Calcium Channel Blocker Conjugates
Application: 14/820,210 →
Publication: US US20150335628A1
Oligomer-Cannabinoid Conjugates
Patent: 8,829,043 →
Application: 12/865,372 →
Publication: US US20120022063A1
Oligomer-Cannabinoid Conjugates
Patent: 9,155,797 →
Application: 14/338,111 →
Publication: US US20140329895A1
Oligomer-Containing Hydantoin Compounds
Patent: 9,540,330 →
Application: 13/994,606 →
Publication: US US20140039020A1
Oligomer-Corticosteroid Conjugates
Patent: 8,796,248 →
Application: 12/680,877 →
Publication: US US20100286107A1
Oligomer-Corticosteroid Conjugates
Application: 14/315,998 →
Publication: US US20140309398A1
Oligomer-Dantrolene Conjugates and Related Compounds
Patent: 8,536,213 →
Application: 12/742,432 →
Publication: US US20100317705A1
Oligomer-Dantrolene Conjugates and Related Compounds
Patent: 9,168,311 →
Application: 13/971,391 →
Publication: US US20130338204A1
Oligomer Modified Diaromatic Substituted Compounds
Patent: 9,226,970 →
Application: 13/580,580 →
Publication: US US20130040961A1
Oligomer-Foscarnet Conjugates
Patent: 9,006,219 →
Application: 12/921,697 →
Publication: US US20110105438A1
Oligomer-Foscarnet Conjugates
Patent: 9,670,235 →
Application: 14/640,686 →
Publication: US US20150175637A1
Oligomer-Nitrogenous Base Conjugates
Application: 12/934,610 →
Publication: US US20110059921A1
Oligomer-Nitroimidazole Anti-Infective Conjugates
Patent: 8,853,247 →
Application: 12/739,605 →
Publication: US US20100317707A1
Oligomer-Nitroimidazole Anti-Infective Conjugates
Patent: 9,233,932 →
Application: 14/477,606 →
Publication: US US20140378520A1
Oligomer-Nucleoside Phosphate Conjugates
Patent: 8,741,858 →
Application: 12/676,128 →
Publication: US US20100286084A1
Oligomer-Nucleoside Phosphate Conjugates
Patent: 9,365,604 →
Application: 14/259,526 →
Publication: US US20140371168A1
Oligomer-Opioid Agonist Conjugates
Patent: 8,575,196 →
Application: 13/386,327 →
Publication: US US20120184581A1
Oligomer-Opioid Agonist Conjugates
Patent: 8,952,032 →
Application: 14/032,648 →
Publication: US US20140200235A1
Oligomer-Opioid Agonist Conjugates
Patent: 9,233,168 →
Application: 14/581,832 →
Publication: US US20150112069A1
Oligomer-Opioid Agonist Conjugates
Patent: 8,173,666 →
Application: 12/558,395 →
Publication: US US20100048602A1
Oligomer-Opioid Agonist Conjugates
Patent: 8,440,687 →
Application: 13/426,521 →
Publication: US US20120264775A1
Oligomer-Opioid Agonist Conjugates
Patent: 8,569,343 →
Application: 13/538,540 →
Publication: US US20120289548A1
Oligomer-Opioid Agonist Conjugates
Patent: 8,946,285 →
Application: 14/032,780 →
Publication: US US20140187790A1
Oligomer-Opioid Agonist Conjugates
Patent: 9,233,167 →
Application: 14/581,721 →
Publication: US US20150238624A1
Oligomer-Diarylpiperazine Conjugates
Patent: 8,685,979 →
Application: 12/864,481 →
Publication: US US20120004242A1
Oligomer-Diarylpiperazine Conjugates
Patent: 9,061,026 →
Application: 14/175,410 →
Publication: US US20140155412A1
Oligomer-Diarylpiperazine Conjugates
Patent: 9,314,463 →
Application: 14/729,578 →
Publication: US US20150335640A1
Oligomer-Phenothiazine Conjugates
Application: 13/146,612 →
Publication: US US20120046279A1
Oligomer-Protease Inhibitor Conjugates
Application: 13/119,107 →
Publication: US US20110195912A1
Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
Patent: 8,816,077 →
Application: 13/264,584 →
Publication: US US20120071492A1
Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
Patent: 9,084,828 →
Application: 14/336,764 →
Publication: US US20140329828A1
Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
Patent: 8,530,492 →
Application: 13/264,519 →
Publication: US US20120071491A1
Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
Patent: 8,921,371 →
Application: 13/963,562 →
Publication: US US20140080839A1
Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
Patent: 9,095,622 →
Application: 14/547,633 →
Publication: US US20150073006A1
Oligomer-Containing Substituted Aromatic Triazine Compounds
Patent: 8,772,479 →
Application: 13/319,824 →
Publication: US US20120122871A1
Oligomer-Containing Substituted Aromatic Triazine Compounds
Patent: 8,895,553 →
Application: 14/282,732 →
Publication: US US20140256732A1
Oligomer-Containing Substituted Aromatic Triazine Compounds
Patent: 9,266,845 →
Application: 14/528,444 →
Publication: US US20150065706A1
Oligomer-Tricyclic Conjugates
Patent: 8,569,380 →
Application: 12/744,467 →
Publication: US US20100298296A1
Oligomer-Tricyclic Conjugates
Patent: 9,725,431 →
Application: 14/020,196 →
Publication: US US20140100268A1
Oligomer-Containing Pyrrolidine Compounds
Patent: 8,785,661 →
Application: 13/319,924 →
Publication: US US20120101145A1
Oligomer-Containing Pyrrolidine Compounds
Patent: 9,096,517 →
Application: 14/297,149 →
Publication: US US20140288315A1
Oligomer-Containing Pyrrolidine Compounds
Patent: 9,399,033 →
Application: 14/751,925 →
Publication: US US20150366842A1
Particle Formation
Patent: 7,087,197 →
Application: 10/197,689 →
Publication: US US20030109421A1
Particle Formation Methods and Their Products
Patent: 7,115,280 →
Application: 10/004,522 →
Publication: US US20020114844A1
Compositions of Particulate Coformulation
Patent: 9,120,031 →
Application: 11/458,008 →
Publication: US US20100222220A1
Compositions of Particulate Coformulation
Application: 14/841,325 →
Publication: US US20150366241A1
Method of Particle Formation
Patent: 6,860,907 →
Application: 10/030,392 →
Method of Particle Formation
Patent: 7,150,766 →
Application: 11/006,464 →
Publication: US US20050206023A1
Particulate Materials
Patent: 7,582,284 →
Application: 10/413,457 →
Publication: US US20030223939A1
Particulate Materials
Patent: 8,080,236 →
Application: 12/483,378 →
Publication: US US20090291050A1
Particulate Materials
Patent: 8,470,301 →
Application: 13/294,881 →
Publication: US US20120058160A1
Particulate Materials
Patent: 8,828,359 →
Application: 13/908,540 →
Publication: US US20140037697A1
Particulate Materials
Patent: 9,616,060 →
Application: 14/451,201 →
Publication: US US20140342002A1
Particulate Materials
Patent: 8,273,330 →
Application: 10/422,342 →
Publication: US US20030232020A1
Particulate Materials
Patent: 7,354,601 →
Application: 10/514,895 →
Publication: US US20050170000A1
Pegylated opioids with low potential for abuse
Application: 61/192,247 →
Pegylated Opioids with Low Potential for Abuse
Application: 13/063,919 →
Publication: US US20110237614A1
Pegylated Opioids with Low Potential for Abuse and Side Effects
Application: 13/521,556 →
Publication: US US20130023553A1
Pharmacologically Active Polymer-G-CSF Conjugates
Application: 61/530,860 →
Poly(Ethylene Glycol) Aldehyde Hydrates and Related Polymers and Applications in Modifying Amines
Patent: 5,990,237 →
Application: 09/082,063 →
Poly(Ethylene Glycol) and Related Polymers Monosubstituted with Propionic or Butanoic Acids and Functional Derivatives Thereof for Biotechnical Applications
Patent: 5,672,662 →
Application: 08/642,231 →
Poly (Ethylene Glycol) Derivatives with Proximal Reactive Groups
Patent: 6,362,254 →
Application: 09/265,989 →
Publication: US US20010011115A1
Poly (Ethylene Glycol) Derivatives with Proximal Reactive Groups
Patent: 6,541,543 →
Application: 09/993,088 →
Publication: US US20020052430A1
Poly(Ethylene Glycol) Derivatives with Proximal Reactive Groups
Patent: 6,437,025 →
Application: 09/992,129 →
Publication: US US20020037949A1
Poly(Ethylene Glycol) Derivatives with Proximal Reactive Groups
Patent: 6,664,331 →
Application: 09/992,102 →
Publication: US US20020040076A1
Polyethylene (Glycol) Derivatives with Proximal Reactive Groups
Patent: 7,030,278 →
Application: 10/668,456 →
Publication: US US20040059025A1
Polyethylene (Glycol) Derivatives with Proximal Reactive Groups
Patent: 7,223,803 →
Application: 11/314,912 →
Publication: US US20060155059A1
Poly (Ethylene Glycol) Derivatives with Proximal Reactive Groups
Patent: 7,528,202 →
Application: 11/799,259 →
Publication: US US20070203264A1
Poly(Ethylene Glycol) Derivatives with Proximal Reactive Groups
Patent: 7,714,088 →
Application: 12/410,438 →
Publication: US US20090186984A1
Polymer Derivatives with Proximal Reactive Groups
Patent: 8,003,742 →
Application: 12/749,399 →
Publication: US US20100184937A1
Polymer-Based Compositions and Conjugates of Non-Steroidal Anti-Inflammatory Drugs
Patent: 8,728,493 →
Application: 11/454,998 →
Publication: US US20070025956A1
Polymer Conjugates of Nesiritide Peptides
Patent: 8,449,872 →
Application: 13/119,215 →
Publication: US US20110165111A1
Polymer Conjugates of Opioid Antagonists
Patent: 7,056,500 →
Application: 10/274,296 →
Publication: US US20030124086A1
Polymer Conjugates of Opioid Antagonists
Patent: 7,662,365 →
Application: 11/332,964 →
Publication: US US20060105046A1
Polymer Conjugates of Opioid Antagonists
Patent: 8,349,307 →
Application: 12/574,335 →
Publication: US US20100105715A1
Polymer Conjugates of Protegrin Peptides
Application: 13/119,216 →
Publication: US US20110171161A1
Polymer Conjugates of Protegrin Peptides
Patent: 9,763,995 →
Application: 14/821,138 →
Publication: US US20160158311A1
Polymer Conjugates of Therapeutic Peptides
Patent: 9,682,153 →
Application: 14/664,582 →
Publication: US US20160022828A1
Carbohydrate-Based Drug Delivery Polymers and Conjugates Thereof
Patent: 8,680,263 →
Application: 13/119,276 →
Publication: US US20110171716A1
Carbohydrate-Based Drug Delivery Polymers and Conjugates Thereof
Patent: 9,173,951 →
Application: 14/167,271 →
Publication: US US20150051371A1
Polymeric Reagents Comprising a Ketone or a Related Functional Group
Patent: 7,208,145 →
Application: 10/751,009 →
Publication: US US20050031576A1
Polymeric reagents comprising a ketone or a related functional group
Patent: 8,865,149 →
Application: 11/714,322 →
Publication: US US20070166277A1
Polymer Derivatives Comprising an Acetal or Ketal Branching Point
Patent: 8,562,965 →
Application: 11/579,465 →
Publication: US US20080299069A1
Polymer Derivatives Comprising an Acetal or Ketal Branching Point
Patent: 9,308,273 →
Application: 14/045,489 →
Publication: US US20140039167A1
Polymer Derivatives Comprising an Imide Branching Point
Patent: 9,085,659 →
Application: 11/579,475 →
Publication: US US20120238640A9
Polymer Derivatives Having Particular Atom Arrangements
Patent: 7,887,789 →
Application: 10/851,691 →
Publication: US US20050009988A1
Conjugates Formed from Polymer Derivatives Having Particular Atom Arrangements
Patent: 7,947,261 →
Application: 11/389,431 →
Publication: US US20060275252A1
Methods for Forming Polymer-Drug Conjugates
Patent: 8,633,277 →
Application: 13/043,438 →
Publication: US US20110178242A1
Pharmaceutical Compositions of Conjugates Formed from Polymer Derivatives Having Particular Atom Arrangements
Patent: 9,044,516 →
Application: 14/136,497 →
Publication: US US20140227218A1
Compositions Comprising a Polymeric Reagent and a Pharmacologically Active Agent
Patent: 9,399,070 →
Application: 14/720,213 →
Publication: US US20150328331A1
Polymer Stabilized Neuropeptides
Patent: 8,008,435 →
Application: 10/647,561 →
Publication: US US20040038899A1
Polymer Stabilized Neuropeptides
Patent: 8,440,623 →
Application: 13/170,760 →
Publication: US US20110257106A1
Polymer-Based Compositions and Conjuates of Hiv Entry Inhibitors
Patent: 9,446,139 →
Application: 11/082,229 →
Publication: US US20050226843A1
Polymer-Based Compositions and Conjugates of Antimicrobial Agents
Patent: 8,273,339 →
Application: 11/402,641 →
Publication: US US20060239960A1
Polymer-Based Compositions and Conjugates of Antimicrobial Agents
Patent: 8,420,068 →
Application: 13/593,183 →
Publication: US US20130059360A1
Polymer-Based Compositions and Conjugates of Antimicrobial Agents
Patent: 8,636,994 →
Application: 13/800,138 →
Publication: US US20130195839A1
Polymer-Des-Ethyl Sunitinib Conjugates
Application: 61/426,893 →
Polymer-Des-Ethyl Sunitinib Conjugates
Application: 13/995,819 →
Publication: US US20140039030A1
Polymer-Factor Ix Moiety Conjugates
Patent: 7,579,444 →
Application: 11/172,459 →
Publication: US US20060052302A1
Polymer-Factor Ix Moiety Conjugates
Patent: 8,586,711 →
Application: 12/638,811 →
Publication: US US20100120982A1
Polymer Factor Ix Moiety Conjugates
Patent: 9,347,054 →
Application: 14/076,116 →
Publication: US US20140141483A1
Polymer-Factor Viii Moiety Conjugates
Patent: 7,199,223 →
Application: 10/789,956 →
Publication: US US20040235734A1
Polymer-Factor Viii Moiety Conjugates
Patent: 7,858,749 →
Application: 11/702,302 →
Publication: US US20080058504A1
Polymer-Factor Viii Moiety Conjugates
Patent: 7,863,421 →
Application: 12/157,072 →
Publication: US US20090041714A1
Polymer-Factor Viii Moiety Conjugates
Patent: 8,133,977 →
Application: 12/636,469 →
Publication: US US20100130427A1
Factor Viii Compositions
Patent: 8,247,536 →
Application: 12/636,594 →
Publication: US US20100120689A1
Polymer Factor Viii Moiety Conjugates
Patent: 8,143,378 →
Application: 12/636,635 →
Publication: US US20100125049A1
Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate
Patent: 8,889,831 →
Application: 13/431,844 →
Publication: US US20120178692A1
Polymer-Factor Viii Conjugate Compositions
Patent: 8,618,259 →
Application: 13/431,862 →
Publication: US US20120245289A1
Polymer Factor Viii Moiety Conjugates
Patent: 8,519,102 →
Application: 13/431,872 →
Publication: US US20120244597A1
Unit Dosage Forms of Pharmaceutical Compositions Comprising a Polymer-Factor Viii Polypeptide Conjugate
Application: 14/517,679 →
Publication: US US20150038422A1
Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method
Patent: 8,492,503 →
Application: 13/063,720 →
Publication: US US20110230618A1
Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method
Patent: 9,228,053 →
Application: 13/925,074 →
Publication: US US20130280783A1
Polymeric Reagents Comprising a Terminal Vinylic Group and Conjugates Formed Therefrom
Patent: 8,268,948 →
Application: 12/374,297 →
Publication: US US20100048707A1
Polymeric Reagents Comprising a Terminal Vinylic Group and Conjugates Formed Therefrom
Patent: 8,905,235 →
Application: 13/590,693 →
Publication: US US20120318701A1
Polymers of N-Acryloylmorpholine Activated at One End and Conjugates with Bioactive Materials and Surfaces
Patent: 5,629,384 →
Application: 08/243,869 →
Polymers of N-Acryloylmorpholine Activated at One End and Conjugates with Bioactive Materials and Surfaces
Patent: 5,631,322 →
Application: 08/475,177 →
Polymer-Semaxanib Moiety Conjugates
Patent: 9,943,605 →
Application: 13/995,301 →
Publication: US US20140011855A1
Polymer-Sunitinib Conjugates
Patent: 9,827,326 →
Application: 13/996,834 →
Publication: US US20130331425A1
Protease inhibitor administration lacking concomitant administration of a CYP3A4 inhibitor
Application: 61/192,417 →
Protease Inhibitors Having Enhanced Features
Application: 13/119,079 →
Publication: US US20110195940A1
Segmented Degradable Polymers and Conjugates Made Therefrom
Patent: 8,309,680 →
Application: 12/224,201 →
Publication: US US20100010158A1
Segmented Degradable Polymers and Conjugates Made Therefrom
Patent: 8,835,599 →
Application: 13/674,854 →
Publication: US US20130072709A1
Chemically Modified Small Molecules
Patent: 7,786,133 →
Application: 11/015,196 →
Publication: US US20050136031A1
Chemically Modified Small Molecules
Patent: 8,067,431 →
Application: 12/710,167 →
Publication: US US20100210676A1
Chemically Modified Small Molecules
Patent: 8,034,825 →
Application: 12/822,935 →
Publication: US US20100305147A1
Chemically Modified Small Molecules
Application: 13/271,158 →
Publication: US US20120088745A1
Chemically Modified Small Molecules
Patent: 9,388,104 →
Application: 14/248,245 →
Publication: US US20150197470A9
Oligomer-Protease Inhibitor Conjugates
Patent: 8,598,364 →
Application: 12/530,363 →
Publication: US US20110269677A1
Oligomer-Protease Inhibitor Conjugates
Patent: 9,107,956 →
Application: 14/055,581 →
Publication: US US20140045770A1
Soluble, Degradable Poly(Ethylene Glycol) Derivatives for Controllable Release of Bound Molecules into Solution
Patent: 6,214,966 →
Application: 08/937,846 →
Soluble, Degradable Poly (Ethylene Glycol) Derivatives for Controllable Release of Bound Molecules
Patent: 6,515,100 →
Application: 09/824,297 →
Publication: US US20010021763A1
Soluble, Degradable Poly (Ethylene Glycol) Derivatives for Controllable Release of Bound Molecules into Solution
Patent: 6,864,350 →
Application: 10/318,322 →
Publication: US US20030220447A1
Soluble, Degradable Poly(Ethylene Glycol) Derivatives for Controllable Release of Bound Molecules into Solution
Patent: 7,655,747 →
Application: 11/051,728 →
Publication: US US20050171328A1
Soluble, Degradable Poly(Ethylene Glycol) Derivatives for Controllable Release of Bound Molecules into Solution
Patent: 8,088,365 →
Application: 12/414,621 →
Publication: US US20090215988A1
Soluble, Degradable Poly(Ethylene Glycol) Derivatives for Controllable Release of Bound Molecules into Solution
Patent: 8,404,222 →
Application: 13/308,361 →
Publication: US US20120071627A1
Stabilized Polymeric Thiol Reagents
Patent: 7,851,565 →
Application: 11/316,051 →
Publication: US US20060135586A1
Stabilized Polymeric Thiol Reagents
Patent: 8,217,123 →
Application: 12/943,740 →
Publication: US US20110112277A1
Stabilized Polymeric Thiol Reagents
Patent: 8,492,488 →
Application: 13/528,103 →
Publication: US US20120258985A1
Stabilized Polymeric Thiol Reagents
Patent: 8,765,883 →
Application: 13/921,889 →
Publication: US US20130280206A1
Stabilized Polymeric Thiol Reagents
Patent: 9,308,274 →
Application: 14/281,411 →
Publication: US US20140256951A1
Stereoselective Reduction of a Morphinone
Patent: 8,183,376 →
Application: 12/297,632 →
Publication: US US20090221766A1
Stereoselective Reduction of a Morphinone
Patent: 8,563,726 →
Application: 13/447,131 →
Publication: US US20130018190A1
Sterically Hindered Poly(Ethylene Glycol) Alkanoic Acids and Derivatives Thereof
Patent: 6,495,659 →
Application: 09/741,933 →
Publication: US US20020002250A1
Sterically Hindered Poly(Ethylene Glycol) Alkanoic Acids and Derivatives Thereof
Patent: 6,737,505 →
Application: 10/283,890 →
Publication: US US20030105275A1
Sterically Hindered Poly(Ethylene Glycol) Alkanoic Acids and Derivatives Thereof
Patent: 6,992,168 →
Application: 10/813,601 →
Publication: US US20050008612A1
Sterically Hindered Poly (Ethylene Glycol) Alkanoic Acids and Derivatives Thereof
Patent: 7,205,380 →
Application: 11/264,546 →
Publication: US US20060069237A1
Sterically Hindered Poly (Ethylene Glycol) Alkanoic Acids and Derivatives Thereof
Patent: 7,405,266 →
Application: 11/716,202 →
Publication: US US20070179274A1
Sterically Hindered Poly(Ethylene Glycol) Alkanoic Acids and Derivatives Thereof
Patent: 7,674,879 →
Application: 12/215,086 →
Publication: US US20080262166A1
Sterically Hindered Poly(Ethylene Glycol) Alkanoic Acids and Derivatives Thereof
Patent: 7,960,502 →
Application: 12/689,979 →
Publication: US US20100121019A1
Sterically Hindered Poly(Ethylene Glycol) Alkanoic Acids and Derivatives Thereof
Patent: 8,183,338 →
Application: 13/099,965 →
Publication: US US20110207896A1
Synthesis of High Molecular Weight Non-Peptidic Polymer Derivatives
Patent: 6,774,180 →
Application: 10/024,357 →
Publication: US US20020082345A1
Segmented Polymers and Their Conjugates
Patent: 7,053,150 →
Application: 10/734,858 →
Publication: US US20040236015A1
Segmented Polymers and Their Conjugates
Patent: 7,834,138 →
Application: 11/402,350 →
Publication: US US20060183855A1
Segmented Polymers and Their Conjugates
Patent: 8,084,572 →
Application: 12/898,687 →
Publication: US US20110021761A1
Segmented Polymers and Their Conjugates
Patent: 8,383,380 →
Application: 13/267,619 →
Publication: US US20120027714A1
Systems and Methods for Driving Sealed Nebulizers
Patent: 9,149,588 →
Application: 13/384,579 →
Publication: US US20120111963A1
Systems and Methods for Driving Nebulizers
Patent: 9,533,118 →
Application: 14/017,531 →
Publication: US US20140007864A1
Systems and Methods for Driving Sealed Nebulizers
Application: 14/842,464 →
Publication: US US20160058958A1
Thioester Polymer Derivatives and Method of Modifying the N-Terminus of a Polypeptide Therewith
Patent: 6,908,963 →
Application: 09/973,318 →
Publication: US US20030105224A1
Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
Patent: 7,078,496 →
Application: 10/269,028 →
Publication: US US20030158333A1
Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
Patent: 7,511,095 →
Application: 11/353,656 →
Publication: US US20060178505A1
Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
Patent: 7,834,088 →
Application: 12/372,727 →
Publication: US US20100069571A1
Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
Patent: 8,071,678 →
Application: 12/902,072 →
Publication: US US20110065862A1
Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
Patent: 8,329,876 →
Application: 13/282,129 →
Publication: US US20120065330A1
Thiol-Selective Water-Soluble Polymer Derivatives
Patent: 7,910,661 →
Application: 10/753,047 →
Publication: US US20050014903A1
Thiol-Selective Water-Soluble Polymer Derivatives
Patent: 8,722,032 →
Application: 13/681,357 →
Publication: US US20130079555A1
Thiol-Selective Water-Soluble Polymer Derivatives
Patent: 9,040,658 →
Application: 14/229,547 →
Publication: US US20140330041A1
Thiol-Selective Water-Soluble Polymer Derivatives
Patent: 9,333,267 →
Application: 14/694,160 →
Publication: US US20150224207A1
Treatment of Pulmonary Disorders with Aerosolized Medicaments Such as Vancomycin
Application: 60/975,094 →
Treatment of Pulmonary Disorders with Aerosolized Medicaments Such as Vancomycin
Application: 12/679,464 →
Publication: US US20100282247A1
Von Willebrand Factor-and Factor Viii-Polymer Conjugates Having a Releasable Linkage
Patent: 8,133,865 →
Application: 12/006,059 →
Publication: US US20080234193A1
Von Willebrand Factor- and Factor Viii-Polymer Conjugates Having a Releasable Linkage
Patent: 8,349,800 →
Application: 13/371,275 →
Publication: US US20120142594A1
Von Willebrand Factor- and Factor Viii-Polymer Conjugates Having a Releasable Linkage
Patent: 9,493,544 →
Application: 13/620,285 →
Publication: US US20130012442A1
Water-Soluble Polymer Conjugates of Artelinic Acid
Patent: 6,461,603 →
Application: 09/794,731 →
Publication: US US20010041172A1
Water-Soluble Polymer Alkanals
Patent: 7,511,094 →
Application: 11/375,698 →
Publication: US US20060194940A1
Water-Soluble Polymer Alkanals
Patent: 7,838,595 →
Application: 12/361,427 →
Publication: US US20090234070A1
Water-Soluble Polymer Alkanals
Patent: 8,076,412 →
Application: 12/908,266 →
Publication: US US20110034737A1
Water-Soluble Polymer Alkanals
Patent: 8,853,325 →
Application: 13/301,715 →
Publication: US US20120065429A1
Water-Soluble Polymer Conjugates of Topotecan
Application: 13/995,063 →
Publication: US US20140371258A1
Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
Application: 14/122,384 →
Publication: US US20140088021A1
Self-Sealing T-Piece and Valved T-Piece
Application: 11/990,587 →
Publication: US US20100126502A1
Solid Salt Form of Alpha-6-MPEG6-O-Hydroxycodone as Opioid Agonists and Uses Thereof
Patent: 9,682,988 →
Application: 14/439,473 →
Publication: US US20150284402A1
Oligomer-Containing Benzamide-Based Compounds
Patent: 9,375,486 →
Application: 14/428,816 →
Publication: US US20150250894A1
Method for Assessing and Predicting Efficacy of Breast Cancer Treatment with a Long-Acting Topoisomerase I Inhibitor
Application: 14/648,042 →
Publication: US US20150309032A1
Method for Predicting and Evaluating Responsiveness to Cancer Treatment with Dna-Damaging Chemotherapeutic Agents
Patent: 9,863,949 →
Application: 14/292,613 →
Publication: US US20140357659A1
Conjugates of an Il-7 Moiety and a Polymer
Application: 62/131,634 →
Compounds
Application: 62/159,120 →
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 15, 2008
From: ZHAO, XUAN; BENTLEY, MICHAEL DAVID; REN, ZHONGXU; VIEGAS, TACEY X.
To: NEKTAR THERAPEUTICS AL, CORPORATION
Reel/Frame 020519/0739 →
Assignment of Assignor's Interest Feb 15, 2008
From: ZHAO, XUAN; BENTLEY, MICHAEL DAVID; REN, ZHONGXU; VIEGAS, TACEY X.
To: NEKTAR THERAPEUTICS AL. CORPORATION
Reel/Frame 020561/0298 →
Merger Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →
Merger Mar 26, 2010
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 024148/0770 →
Grant of Security Interest Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
Assignment of Assignor's Interest Mar 13, 2013
From: CHONG, ANTHONY O.; LEE, SEOJU; JOSHI, BHALCHANDRA V.; BRAY, BRIAN
To: NEKTAR THERAPEUTICS
Reel/Frame 029987/0001 →
Security Agreement Mar 19, 2013
From: NEKTAR THERAPEUTICS
To: WELLS FARGO, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030040/0952 →
Assignment of Assignor's Interest Apr 16, 2013
From: FINK, JAMES B.; KADRICHU, NANI P.
To: NEKTAR THERAPEUTICS
Reel/Frame 030223/0724 →
Security Agreement Sep 16, 2013
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 031217/0776 →
Security Agreement Dec 18, 2013
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 031838/0343 →
Security Interest Jun 9, 2014
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 033105/0898 →
Security Interest Dec 4, 2014
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 034378/0972 →
Release of Security Interest Recorded at Reel 28571, Frame 0141 Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
Release of Security Interest Recorded at Reel 31838, Frame 0343 Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036876/0138 →
Release of Security Interest Recorded at Reel 33105, Frame 0898 Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036855/0524 →
Release of Security Interest Recorded at Reel 30040, Frame 0952 Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036855/0793 →
Release of Security Interest Recorded at Reel 34378, Frame 0972 Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036855/0558 →
Release of Security Interest Recorded at Reel 31217, Frame 0776 Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036876/0130 →
Release of Security Interest Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →